Funding Opportunity: Comprehensive Geriatric Assessment (CGA)

Mixed consortia of robot manufacturers and research institutes have the opportunity to apply for a total funding of 1.2 million Euros in a competitive process in order to develop small-scale test series as solutions for the given challenge. AQuAS (Agència de Qualitat I Avaluació Sanitàries de Catalunya), a public entity of the Catalan Department of Health, and Fundació Privada Sant Antoni Abat, a non-profit private foundation managing and developing innovation and research in healthcare, have defined the Comprehensive Geriatric Assessment (CGA) challenge. This challenge specifies the requirements of the public bodies for a robotic product that is not yet available on the market.

The Comprehensive Geriatric Assessment (CGA) is a diagnostic instrument designed to collect data on the medical, psychosocial and functional resources and problems of elderly patients. The information gathered is used to create a plan for treatment and followup. Currently, CGA is performed by social and clinical professionals involved in the care of elderly people: physiotherapists, occupational therapists, nurses, social workers, psychologists, medical doctors, etc. The goal of utilizing a robot to control and to conduct the geriatric tests is to reduce the amount of time medical professionals spend on taking tests and thereby enable them to invest this time oncare planning decisions. In order to master this challenge, multi-institutional consortia or development teams will need to apply for funding in a competitive process in order to develop prototypes according to the needs of the public bodies.

The aim of ECHORD++ (European Clearing House for Open Robotics Development Plus Plus) is to strengthen the knowledge transfer between scientific research, industry and users in robotics and to stimulate their cooperation. The EU-funded project with a runtime of five years (2013 - 2018) funds small-scale research projects called experiments, Public end-user Driven Technological Innovation (PDTI), and established Robotics Innovation Facilities (RIFs), open labs which provide state-of-the-art robotic hardware and software as well as scientific and technical support. ECHORD++ is a joint project of Technische Universität München (project coordinator), Blue Ocean Robotics, Bristol Robotics Laboratory, Commissariat à l’Énergie Atomique et aux Énergies Alternatives, R.U. Robots, Scuola Superiore Sant’Anna, TechnoDeal and Universitat Politècnica de Catalunya.

The idea behind Public end-user Driven Technological Innovation (PDTI) in ECHORD++ is to include public bodies in the robotic product development. By acting as technologically demanding first buyers, public procurers can drive innovation from the demand side and promote the transfer of robotic technology from research to the market. Since public bodies often have specific requirements for the products they use, ECHORD++ will strive to find the best way to integrate them in the product development process. This is to make sure that the product meets the requirements of the target group, technically and price-wise. Thus, ECHORD++ hopes to close the innovation gap between what is available on the market and the public sector's needs.

Closing date: 23rd June 2015

For further information about PDTI, please visit:
http://www.echord.eu/pdti/

E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Tel.: +49 89 289 18136

The project ECHORD++ is funded under EU’s Seventh Framework Programme for Research (FP7), Grant Agreement No. 601116.

Most Popular Now

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...